A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence. (Q44331658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

José Pérez de los Cobos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Joan Trujols

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Francesca Batlle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

S Martin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Etcheberrigaray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Tejero

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J M Queraltó

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Casas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

Drug and Alcohol Dependence

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

223-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

Alternate-day dosing during buprenorphine treatment of opioid dependence

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

The development of an opiate withdrawal scale (OWS)

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Plasma concentrations of buprenorphine 24 to 72 hours after dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Naloxone reversal of buprenorphine-induced respiratory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine suppresses heroin use by heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine: duration of blockade of effects of intramuscular hydromorphone.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900122-2

7 January 2021

10.1016/S0376-8716(99)00122-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812283%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference